PéptidosRD.COM

Single Peptides · Exact presentation

Vesugen (Lys-Glu-Asp) · 20 mg Vial

Vesugen (Lys-Glu-Asp) · 20 mg Vial is an exact single peptide or compound entry. This strength is kept separate because concentration and calculations depend on vial amount.

Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.

Dosing & Reconstitution Guide

For a 20 mg presentation, the reference concentration of 6.67 mg/mL mathematically corresponds to 2.999 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 6.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0667 mg at this concentration.

Standard / Gradual Approach (3 mL = ~6.67 mg/mL)

The source chart summarizes “500 mcg–2 mg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.

Standard / Gradual Approach (3 mL = ~6.67 mg/mL)

WeekDaily Dose (mcg)Units (per injection) (mL)
Week 1500 mcg (0.5 mg)7.5 units (0.075 mL)
Week 21000 mcg (1.0 mg)15 units (0.15 mL)
Week 31500 mcg (1.5 mg)22.5 units (0.225 mL)
Weeks 4–8+1500–2000 mcg (1.5–2.0 mg)22.5–30 units (0.225–0.30 mL)

Reconstitution Steps

For a 20 mg presentation, the reference concentration of 6.67 mg/mL mathematically corresponds to 2.999 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 6.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0667 mg at this concentration.

Storage Instructions

Proper storage preserves peptide quality.

Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]

Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]

Allow vials to reach room temperature before opening to reduce condensation uptake.

How This Works

It is described as a short peptide or bioregulator with proposed tissue-signaling effects. Mechanisms and targets are often less established than for well-characterized medicines.

Potential Benefits & Side Effects

Uncertainty about identity, pharmacology, efficacy, and safety is material. A biological hypothesis should not be presented as a demonstrated benefit.

Source trail

Scientific references and source discovery

How PeptidosRD selects, separates, and reviews sources